Managed Account Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Managed Account Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$3.29M	Buy	43,739 +808	+2%	+$43.3K	﹤0.01%	1621
2015 Q1	$2.15M	Buy	42,931 +2,661	+7%	+$112K	﹤0.01%	1817
2014 Q4	$1.4M	Sell	40,270 -4,597	-10%	-$160K	﹤0.01%	1962
2014 Q3	$1.47M	Buy	44,867 +1,363	+3%	+$48K	﹤0.01%	1918
2014 Q2	$1.67M	Buy	43,504 +17,790	+69%	+$621K	﹤0.01%	1838
2014 Q1	$1.02M	Sell	25,714 -155	-0.6%	-$6.93K	﹤0.01%	1951
2013 Q4	$966K	Buy	+25,869	New	+$1.07M	﹤0.01%	1924

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Managed Account Advisors's KYTH Position: Q2 2015 in Review

Managed Account Advisors increased its KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) stake by 1.9% in Q2 2015, buying an estimated $43.3K and bringing the position to 43,739 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1621.

Managed Account Advisors first reported a position in KYTH in Q4 2013 and has held it in 7 quarters since. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

Managed Account Advisors held 43,739 shares of KYTHERA BIOPHARMACEUTICALS, INC COM worth $3.29M as of Q2 2015.
Managed Account Advisors bought 808 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $43.3K.
KYTHERA BIOPHARMACEUTICALS, INC COM made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1621 holding.
Managed Account Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and has held it in 7 quarters since.
153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.